Guideline on the clinical investigation of medicines for the treatment of Alzheimer’s disease (original) (raw)

Alzheimer’s Disease: Cellular and Pharmacological Aspects

Donají Chi-Castañeda

Geriatrics, 2024

View PDFchevron_right

Prise en charge non pharmacologique des troubles du comportement dans la maladie d’Alzheimer

Laure Carcaillon

Annales Médico-psychologiques, revue psychiatrique, 2009

View PDFchevron_right

Treatment of Alzheimer's disease across the spectrum of severity

Shailaja Shah

Clinical Interventions in Aging, 2006

View PDFchevron_right

Novel Therapeutic Strategies for Alzheimer??S Disease and Related Disorders

Soraya Sajadimajd

Alzheimer Disease & Associated Disorders, 1988

View PDFchevron_right

Alzheimer’s disease pathogenesis and therapeutic interventions

Adaeze Echezona, john ogbodo

Journal of Clinical Neuroscience, 2004

View PDFchevron_right

Efficacy of Beta-Secretase-1 Enzyme Inhibitors in Alzheimer's Disease

roohalah yosefi

Advanced Pharmacy Research, 2023

View PDFchevron_right

Alzheimer’s disease therapies: Selected advances and future perspectives

Abdelaziz Ghanemi, PhD

Alexandria Journal of Medicine, 2015

View PDFchevron_right

Traditional and Modern Medicine Harmonizing the Two Approaches in the Treatment of Neurodegeneration (Alzheimer’s Disease – AD)

Bishara Bisharat

Complementary Therapies for the Contemporary Healthcare, 2012

View PDFchevron_right

Alzheimer’s Disease Biochemical and Clinical Implications

Dr.Entedhar R . Sarhat

View PDFchevron_right

Early diagnosis and treatment of Alzheimer’s disease

Brigitte Guérin

Expert Review of Neurotherapeutics, 2008

View PDFchevron_right

A century of confusion in researching Alzheimer’s disease

Mario Garrett

International Journal of Healthcare, 2016

View PDFchevron_right

Alzheimer’s disease therapeutic trials: EU/US task force report on recruitment, retention, and methodology

Maria Carrillo

The journal of nutrition, health & aging, 2012

View PDFchevron_right

Dementia (Re)performed

Pia Kontos

Care Home Stories, 2017

View PDFchevron_right

Optimum Design of Disease-Modifying Trials on Alzheimer's Disease

Yan Yan

Statistics in Biopharmaceutical Research, 2012

View PDFchevron_right

BRAIN Journal - New Computer Assisted Diagnostic to Detect Alzheimer Disease

Hamid Amiri

Zenodo (CERN European Organization for Nuclear Research), 2016

View PDFchevron_right

Editorial: The Alzheimer's Disease Challenge

Athanasios T Alexiou

Frontiers in Neuroscience, 2019

View PDFchevron_right

Current and novel therapeutic molecules and targets in Alzheimer's disease

Timir Tripathi

Journal of the Formosan Medical Association, 2016

View PDFchevron_right

Alzheimer's disease: Molecular genetics and transgenic animal models

Ronnie Folkesson

Behavioural Brain Research, 1993

View PDFchevron_right

A New Regulatory Road-Map for Alzheimer’s Disease Drug Development

Nigel Greig

Current Alzheimer Research, 2014

View PDFchevron_right

Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Yuen So

2008

View PDFchevron_right

Editorial: New challenges and future perspectives in neurodegeneration

Hamid R Sohrabi

Frontiers in Neuroscience, 2022

View PDFchevron_right

Neuropharmacology of depression in aging and age-related diseases

Pietro Gareri

Ageing Research Reviews, 2002

View PDFchevron_right

Aripiprazole in the treatment of Alzheimer's disease

Peter Paul De Deyn

Expert Opinion on Pharmacotherapy, 2013

View PDFchevron_right

30ièmes Journées Franco-Belges de Pharmacochimie

Jean-michel Bolla

Pharmaceuticals, 2016

View PDFchevron_right

Frequency and Severity of Adverse Drug Reactions to Medications Prescribed for Alzheimer’s Disease in a Brazilian City: Cross-Sectional Study

Luciane Lopes

Frontiers in Pharmacology, 2020

View PDFchevron_right

Alzheimer鈥檚 Disease: Recent Advances

Rita Kakkar

Journal of biochemistry and molecular biology research, 2015

View PDFchevron_right

Alzheimer's disease research and development: A call for a new research roadmap

Richard Mayeux

2014

View PDFchevron_right

Presenilins and Alzheimer's disease

Dmitry Goldgaber

Current Opinion in Neurobiology, 1997

View PDFchevron_right

Pharmacologic modelling of Alzheimer's disease

P. Tariot

Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1986

View PDFchevron_right

Selective Loss of Cerebral Keratan Sulfate in Alzheimer's Disease

D. Spillmann

Journal of Biological Chemistry, 1996

View PDFchevron_right

Treatment for Breast Cancer in Patients with Alzheimer's Disease

Sherri Gorin

Journal of the American Geriatrics Society, 2005

View PDFchevron_right

Clearance of Alzheimer's Aβ Peptide

Rudy Tanzi

Neuron, 2004

View PDFchevron_right

Alzheimer’s disease is not “brain aging”: neuropathological, genetic, and epidemiological human studies

Gregory Jicha

Acta Neuropathologica, 2011

View PDFchevron_right

Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease

Fabrizio Piazza

Neurobiology of Aging, 2012

View PDFchevron_right

Risk Factors and Current Strategies to Overcome Alzheimer’s Disease: A Review

Manjunatha mudagal

International Journal of Research in Ayurveda and Pharmacy, 2020

View PDFchevron_right